Discussion:
More evidence in favor of BAT (Bipolar Androgen Therapy)
(too old to reply)
Alan Meyer
2017-09-09 03:14:32 UTC
Permalink
Here's a new study supporting high testosterone as a treatment for
prostate cancer, at least in mice.

Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28877700

Full text:
https://bmccancer.biomedcentral.com/articles/10.1186/s12885-017-3569-x

Alan
Ed Friedman
2017-09-19 21:32:30 UTC
Permalink
This result is not at all surprising. It is too bad that the researchers
did not continue to increase the testosterone (T) concentration to see
at what point the improvement ceases and the results start to plateau.
Considering that T has virtually no adverse side effects in men (See:
http://www.brazjurol.com.br/march_april_201/Editors_Comment_195_198.htm)
other than too much estadiol and too many red blood cells (both of which
are easily monitored and rectified), this information would be essential
to guide clinical trials in men.

Ed Friedman
Post by Alan Meyer
Here's a new study supporting high testosterone as a treatment for
prostate cancer, at least in mice.
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28877700
https://bmccancer.biomedcentral.com/articles/10.1186/s12885-017-3569-x
   Alan
I.P. Freely
2017-09-23 23:01:40 UTC
Permalink
Last time I asked Leibowitz/Eshaghian, they highly recommended your
recent book, Ed, but don't use your aromatase inhibitor protocol. Maybe
the difference is because their high T treatment is not bipolar. Have
you and they made any progress towards resolving the difference of opinion?

I can't get your link to work.

I.P.
Post by Ed Friedman
This result is not at all surprising. It is too bad that the researchers
did not continue to increase the testosterone (T) concentration to see
at what point the improvement ceases and the results start to plateau.
http://www.brazjurol.com.br/march_april_201/Editors_Comment_195_198.htm)
other than too much estadiol and too many red blood cells (both of which
are easily monitored and rectified), this information would be essential
to guide clinical trials in men.
Ed Friedman
Ed Friedman
2017-09-25 18:12:51 UTC
Permalink
I.P.

I'm pretty sure that they would give you anastrozole once you are on
high T if you were to ask. Probably 1/4 of a pill a day should be
sufficient for most people, but it is best to occasionally monitor your
estradiol level if you do go on high T.

Ed Friedman
Post by I.P. Freely
Last time I asked Leibowitz/Eshaghian, they highly recommended your
recent book, Ed, but don't use your aromatase inhibitor protocol. Maybe
the difference is because their high T treatment is not bipolar. Have
you and they made any progress towards resolving the difference of opinion?
I can't get your link to work.
I.P.
Post by Ed Friedman
This result is not at all surprising. It is too bad that the
researchers did not continue to increase the testosterone (T)
concentration to see at what point the improvement ceases and the
results start to plateau. Considering that T has virtually no adverse
http://www.brazjurol.com.br/march_april_201/Editors_Comment_195_198.htm)
other than too much estadiol and too many red blood cells (both of
which are easily monitored and rectified), this information would be
essential to guide clinical trials in men.
Ed Friedman
I.P. Freely
2017-09-26 01:48:16 UTC
Permalink
Unless and until I find the time to research it further (including
re-reading your latest book), I'd ask them to explain their position and
would probably defer to their advice. We won't be discussing the high T
option until February arrives and my numbers still warrant it so I have
time to ponder and read.

I.P.
Post by Ed Friedman
I.P.
I'm pretty sure that they would give you anastrozole once you are on
high T if you were to ask. Probably 1/4 of a pill a day should be
sufficient for most people, but it is best to occasionally monitor your
estradiol level if you do go on high T.
Ed Friedman
William Lewis
2018-04-02 03:01:58 UTC
Permalink
Regarding Ed Friedman's post of 9/17/17, here is the article link:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752079/
What was missing was that the article was from 2015.
I.P. Freely
2018-04-02 23:38:13 UTC
Permalink
The research I've been doing on my non-bipolar (i.e., constant) high-T
treatment protocol brings me across many references to BAT or to
ordinary TRT in PC patients. Every such study and meta-analysis I've
seen suggests either that TRT does not affect PC or at least that there
is no evidence to support the [outdated?] hypothesis that TRT harms men
with prostate cancer. That's just one of many reasons I chose my high-T
protocol. Maybe I'll still be smearing T gel over my shoulders and belly
when I die from a heart attack or a meteor strike 20 years from now.

Dr. Leibowitz has been doing this since way last century, and his
published data show a far higher success rate than surgery or radiation
with *FAR* less frequent or severe adverse effects. His data support his
conviction that such invasive procedures are very often archaic and
unnecessary for many men.

I.P.
Post by William Lewis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752079/
What was missing was that the article was from 2015.
Loading...